iReceptor mentioned in Financial Times COVID-19 Article

Felix Breden, Scientific Director of iReceptor, was interviewed by the Financial Times on the efforts of the iReceptor team to curate multiple studies of COVID-19 patients. In a broad-ranging article on immunogenetics approaches to COVID-19 research, Dr. Breden was quoted as saying, “When you are exposed to a virus, your immune system selects the arrangements that can best deal with the infection, copies them and expands these clones very rapidly.” The extensive article reported that the iReceptor Gateway queries >200M receptor sequences from COVID-19 patients, which is up to over 500M as of September 25th!